144 related articles for article (PubMed ID: 6752447)
1. A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients.
Sherwin SA; Knost JA; Fein S; Abrams PG; Foon KA; Ochs JJ; Schoenberger C; Maluish AE; Oldham RK
JAMA; 1982 Nov; 248(19):2461-6. PubMed ID: 6752447
[TBL] [Abstract][Full Text] [Related]
2. Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial.
Sherwin SA; Mayer D; Ochs JJ; Abrams PG; Knost JA; Foon KA; Fein S; Oldham RK
Ann Intern Med; 1983 May; 98(5 Pt 1):598-602. PubMed ID: 6342490
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.
O'Connell MJ; Colgan JP; Oken MM; Ritts RE; Kay NE; Itri LM
J Clin Oncol; 1986 Feb; 4(2):128-36. PubMed ID: 3511183
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of recombinant leukocyte A interferon in advanced malignant melanoma.
Elsässer-Beile U; Drees N; Neumann HA; Schöpf E
J Cancer Res Clin Oncol; 1987; 113(3):273-8. PubMed ID: 3584216
[TBL] [Abstract][Full Text] [Related]
6. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
Furue H
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
[TBL] [Abstract][Full Text] [Related]
7. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in skin malignant tumors].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):936-42. PubMed ID: 2985007
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia.
Foon KA; Bottino GC; Abrams PG; Fer MF; Longo DL; Schoenberger CS; Oldham RK
Am J Med; 1985 Feb; 78(2):216-20. PubMed ID: 3970047
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunologic effects of recombinant leukocyte A interferon in eight patients with advanced cancer.
Horning SJ; Levine JF; Miller RA; Rosenberg SA; Merigan TC
JAMA; 1982 Mar; 247(12):1718-22. PubMed ID: 6174742
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
11. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor].
Furue H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861
[TBL] [Abstract][Full Text] [Related]
12. Prospectively randomized toxicity study of high-dose versus low-dose treatment strategies for lymphoblastoid interferon.
Silver HK; Connors JM; Salinas FA
Cancer Treat Rep; 1985; 69(7-8):743-50. PubMed ID: 4016785
[TBL] [Abstract][Full Text] [Related]
13. Human alpha-lymphoblastoid interferon. A phase I study including pharmacokinetics and effects on hematologic stem cells (CFU-GMs).
Sarna G; Figlin R; Bryson Y; Garratty E; Myers L; Le Fevre C; Mauritzon N; Cline M
Am J Clin Oncol; 1985 Oct; 8(5):406-12. PubMed ID: 4061375
[TBL] [Abstract][Full Text] [Related]
14. Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients.
Creagan ET; Ahmann DL; Frytak S; Long HJ; Chang MN; Itri LM
Cancer Treat Rep; 1986 May; 70(5):619-24. PubMed ID: 3518925
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma.
Creagan ET; Ahmann DL; Green SJ; Long HJ; Frytak S; O'Fallon JR; Itri LM
J Clin Oncol; 1984 Sep; 2(9):1002-5. PubMed ID: 6470751
[TBL] [Abstract][Full Text] [Related]
16. Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon.
Maluish AE; Ortaldo JR; Conlon JC; Sherwin SA; Leavitt R; Strong DM; Weirnik P; Oldham RK; Herberman RB
J Immunol; 1983 Jul; 131(1):503-7. PubMed ID: 6863923
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of combinations of recombinant interferons beta(ser) and gamma in patients with advanced malignancy.
Schiller JH; Storer B; Willson JK; Borden EC
Cancer Treat Rep; 1987 Oct; 71(10):945-52. PubMed ID: 3115570
[TBL] [Abstract][Full Text] [Related]
18. [Phase II study of recombinant human leukocyte A interferon on urogenital cancer patients].
Yoshimoto J; Tsushima T; Matsumura Y; Ohmori H; Saito N; Tanaka H; Asahi T; Ohkita K; Tanahashi T; Nanba K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):465-70. PubMed ID: 4004282
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers].
Kasamatsu T; Ohmi K; Takeuchi S; Takamizawa H; Matsuzawa M; Kawana T; Ueda K; Kubo H; Tsumuji Y; Kawashima Y
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1656-60. PubMed ID: 3896157
[TBL] [Abstract][Full Text] [Related]
20. A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer.
Sherwin SA; Foon KA; Abrams PG; Heyman MR; Ochs JJ; Watson T; Maluish A; Oldham RK
J Biol Response Mod; 1984 Dec; 3(6):599-607. PubMed ID: 6439828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
